Log In
Print this Print this


Also known as: 1399686

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionOral anti-inflammatory macrolide conjugate
Molecular Target Ribosomal 50S subunit
Mechanism of ActionRibosomal 50S subunit inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat inflammatory bowel disease (IBD); Treat mild to moderate ulcerative colitis (UC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today